Review the Research Behind Pediatric Gender Medicine

Nowhere is the commitment to “Do No Harm” more important than the care of our children and teenagers, which is why we seek to have a constructive dialogue with the Endocrine Society and its members on how best to help gender-diverse children and adolescents.

European vs. United States Approach

Research shows that the U.S. is increasingly out of step with its European counterparts on pediatric gender medicine:

• Health authorities in Sweden and Finland have rolled back “gender-affirming” hormonal interventions, acknowledging them as “an experimental practice.”
• Health authorities in Norway, France, the UK, and Australia have meantime urged “great caution” in the face of unproven benefits and serious—and to date largely unknown—medical risks.
• An investigative report published earlier this year in the prestigious British Medical Journal found that recommendations in support of “gender-affirming care” for minors are not “evidence-based.”
• The Endocrine Society clinical practice guidelines from 2017 are based on two systematic reviews of evidence and judged the quality of evidence behind its own recommendations for hormonal interventions as “low” or “very low.”

These are just a few examples illustrating why there is an urgent need for the Endocrine Society to reassess the nature and scope of its commitment to the affirmative model of care.

Current Standards Are Causing Harm

The heartbreaking consequence of the United States’ affirmation-only approach to pediatric gender medicine is the increasing number of “detransitioned” teenagers and young adults. These brave advocates come forward to tell us that they have been irreversibly harmed by well-intentioned endocrinologists.

One such advocate is Chloe, an 18 year old detransitioner from The Central Valley of California. We invite you to hear her story:

You’re Not Alone In Expressing Concern

It is clear that there is no consensus on “gender-affirming” care for minors within the endocrinologist community. By reviewing the research on pediatric gender medicine, our international colleagues have helped prevent children from undergoing potentially life-changing, irreversible procedures.

Now is the time for the Endocrine Society to reassess the nature and scope of its commitment to the affirmative model of care so that American endocrinologists can provide the best evidence-based treatment for minors.

Please sign up below to learn more about this issue.